Cipla, Pfizer ink partnership for exclusive marketing of four brands in IndiaPfizer India and Cipla Limited have announced a strategic partnership where Cipla will exclusively market and distribute four of Pfizer's k...
SC to Vedanta: Why not use arbitration to resolve Corex disputeCounsel Utsav Trivedi, appearing for Corex, told the Bench that the company had agreed to provide its services on the assurance given by Ve...
Pfizer posts Rs 60.5 cr net profit in December quarterRevenue for the quarter ended December 31, 2016 was Rs 504 crore as compared to Rs 521 crore in the same period last year.
Delhi High Court quashes government ban on over 300 medicines like Corex, SaridonThe brands included D'Cold Total, Corex cough syrup, and Vicks Action 500, among others.
Delhi High Court verdict on combination drugs ban likely todayEndlaw is expected to give his verdict even as the government has submitted a petition to transfer all FDC cases across the country to the ...
Pfizer withdraws Corex syrup, extends line to new productsAccording to Pfizer, with this formulation, all additional line extensions will be introduced with all due regulatory approvals in place.
Delhi HC questions government's decision; drug ban saga continuesPfizer’s cough syrup Corex, which had received a ‘No Objection Certificate’ (NOC) from DCGI in 1995, was brought up as an example during th...
More than 500 drugs may face banHealth ministry, which banned 344 fixed-dose combinations including cough syrups like Phensedyl, Corex and Benadryl, is evaluating a list o...
P&G stops selling Vicks Action 500 Extra in India after banP&G said all its products, including Vicks Action 500 Extra, were backed by research to support their quality, safety and efficacy.
Delhi High Court stays Corex ban on Pfizer’s petitionThe order is estimated to impact pharmaceutical brands worth Rs 3,800 crore sold in the Indian market, according to market research experts.
Shares of Pfizer plunge on the BSE following Corex banHowever, Abbott India that sells another popular cough syrup Phensedyl, also in the list of banned drugs, closed marginally higher.
Pfizer, Abbott stop sale of cough syrups in India post banCorex is a combination of chlopheniramine maleate and codeine syrup - one of 344 drug combinations India banned over the weekend.
- Essar Steel commissioned 0.87-million-tonne corex module
Essar Steel, the Ruia-promoted steel plant, has commissioned a 0.87-million-tonne corex module at Hazira.
- HC provides relief to Pfizer on trade mark battle over COREX
On a plea by global pharma major Pfizer, the Delhi High Court today restrained Ahmedabad-based Stallion Laboratories from manufacturing and...
- Voveran pips Corex to emerge best seller
Novartis’ painkiller, Voveran, has emerged as the best-selling drug in the country.
- Pfizer, Nicholas Piramal hit by codeine shortage
Hit by the shortage of raw material codeine, India’s highest selling drug (in value) Pfizer’s cough syrup Corex has slipped to the eighth s...
- Pfizer, NPIL abused by drug addicts
Pfizer's Corex and Nicholas Piramal's Phensedyl give a 'kick' to drug addicts, say experts.